Featured Content

Joseph Bailes, MD
National Health Policy Expert

Lawmakers Unveil Bill to Prevent Medicare Cuts to Doctors

(The Hill) Mar 19, 2015 - Bipartisan committee leaders in the House and Senate introduced legislation Thursday to permanently end automatic cuts to doctors under Medicare.

Commentary: This is welcome news and should be supported. However, there may be resistance in the Senate and among some members...

OBR Daily   Our free daily oncology focused e-news service.
Subscribe»  |  Search Archives»

Today's News

Europe Postpones Decision On Bristol Immune System Cancer Drug

(Reuters) Mar 27, 2015 - European regulators have postponed a decision on whether to recommend approval of a closely watched Bristol-Myers Squibb drug that helps the immune system fight cancer, a spokeswoman for the European Medicines Agency said on Friday.
read article »

MorphoSys Plunges Most Since 2002 After Ending Pact With Celgene

(Bloomberg) 26, 2015 - MorphoSys AG plunged the most in more than 12 years after it ended a collaboration with Celgene Corp. to develop a cancer drug, less than two years into the partnership.
read article »


View ALL News »

News Story Commentary By Academic and Community Oncologists

Lawmakers Unveil Bill to Prevent Medicare Cuts to Doctors (The Hill)

This is welcome news and should be supported. However, there may be resistance in the Senate and among some members...posted by: Joseph Bailes, MD

Drugmakers Turn Heat on Insurers by Backing Copay Limits (Bloomberg)

While I am somewhat in agreement that copay should be limited at some level, I find the backing by the manufacturers...posted by: Winston Wong, PharmD

ICD-10 Delay Soon Could be Back on Table (HealthData Management)

I have to wonder if ICD-10 will ever become a reality.posted by: Winston Wong, PharmD

Report: Specialty Drugs Drive Prescription Spending Jump (ABC News/Associated Press)

No doubt that specialty drug spending is driving higher trends. Hep C started the ball rolling faster, and anticipated...posted by: Winston Wong, PharmD

In Cancer Wars, It's Doctors vs. Hospitals (MedPage Today/HealthLeaders Media)

There truly is a huge disconnect in the system. Presently the system rewards more expensive care in the hospital...posted by: Thomas Marsland, MD

OBR Training

Learn more about the OBR training platform, developed to provide an in-depth understanding of the unique business dynamics of today's oncology landscape.

OBR Job Board

Bayer has posted 8 new jobs.

Check out the OBR Job Board here.

Sponsored Content

Colon Cancer Awareness

Colorectal cancer (CRC) is one of the most commonly diagnosed cancers worldwide. Kantar Health's new interactive colorectal cancer (CRC) infographic highlights the unmatched global reach of oncology data from our best-in-class data sources. The infographic captures data from Japan, Germany, China, Brazil and the U.S. - a small sample of our global capabilities.

View Infographic >>


The most comprehensive and up-to-date oncology pipeline information on the web!
OBR Pipeline Online™

View company profiles, indexes, and streaming stock quotes of over 200 oncology focused companies.


Symbol  %Δ
BMRN +11.45%
CALA +9.89%
VICL +7.92%
OHRP -68.61%
LOXO -7.79%
IMDZ -6.08%


OBR Radar

View upcoming pivotal oncology events such as PDUFA dates, ODAC dates, and announcement of phase III clinical trial results

Date: March 2015
Company: Nektar Therapeutics
Product: NKTR-102

Date: Q1 2015
Company: Cell Therapeutics
Product: pacritinib

Date: Q2 2015
Company: Exelixis
Product: cabozantinib

See All OBR Radar items»